Literature DB >> 8223603

The glycosylphosphatidylinositol anchor of the trypomastigote-specific Tc-85 glycoprotein from Trypanosoma cruzi. Metabolic-labeling and structural studies.

A S Couto1, R M De Lederkremer, W Colli, M J Alves.   

Abstract

The Tc-85 glycoprotein, specific for the infective stage of Trypanosoma cruzi, is anchored via glycosylphosphatidylinositol. The protein was purified from parasites, labeled metabolically with palmitic acid, by immunoprecipitation with the H1A10 monoclonal antibody or by affinity column chromatography on wheat germ agglutinin. Antisera to the soluble form of the variant surface glycoprotein of Trypanosoma brucei brucei cross-reacted with Tc-85 when the immunoprecipitate was analysed by Western blotting. The reaction was intensified upon previous incubation of the glycoprotein with phosphatidylinositol-specific phospholipase C. Such recognition was abolished when the cyclic phosphate was opened by mild acid treatment. The lipid cleaved by phospholipase C digestion, was identified as 1-O-hexadecylglycerol by reverse-phase thin-layer chromatography. The glycan core was deaminated and chemically labeled by reduction with NaB3H4. The labeled glycoprotein was exhaustively treated with pronase and dephosphorylated with 50% HF. Although microheterogeneity of the oligosaccharide moiety was apparent, by thin layer chromatography, a main spot coincident with Man(alpha 1-2) Man(alpha 1-6) Man(alpha 1-4) anhydromannitol was shown, consistent with the conserved core structure of all glycosylphosphatidylinositol anchors analysed to date.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8223603     DOI: 10.1111/j.1432-1033.1993.tb18282.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents.

Authors:  I C Almeida; M M Camargo; D O Procópio; L S Silva; A Mehlert; L R Travassos; R T Gazzinelli; M A Ferguson
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

2.  Evidence for phospholipases from Trypanosoma cruzi active on phosphatidylinositol and inositolphosphoceramide.

Authors:  L E Bertello; M J Alves; W Colli; R M de Lederkremer
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

3.  Structural analysis of inositol phospholipids from Trypanosoma cruzi epimastigote forms.

Authors:  L E Bertello; M F Gonçalvez; W Colli; R M de Lederkremer
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

4.  Analysis of glycosylphosphatidylinositol membrane anchors by electrospray ionization-mass spectrometry and collision induced dissociation.

Authors:  C A Redman; B N Green; J E Thomas-Oates; V N Reinhold; M A Ferguson
Journal:  Glycoconj J       Date:  1994-06       Impact factor: 2.916

5.  The glycoinositol-phospholipids of Phytomonas.

Authors:  C A Redman; P Schneider; A Mehlert; M A Ferguson
Journal:  Biochem J       Date:  1995-10-15       Impact factor: 3.857

6.  The Sphingolipid Biosynthetic Pathway Is a Potential Target for Chemotherapy against Chagas Disease.

Authors:  Carolina Macedo Koeller; Norton Heise
Journal:  Enzyme Res       Date:  2011-04-19

7.  Specific Recognition of β-Galactofuranose-Containing Glycans of Synthetic Neoglycoproteins by Sera of Chronic Chagas Disease Patients.

Authors:  Alba L Montoya; Eileni R Gil; Emily L Heydemann; Igor L Estevao; Bianca E Luna; Cameron C Ellis; Sohan R Jankuru; Belkisyolé Alarcón de Noya; Oscar Noya; Maria Paola Zago; Igor C Almeida; Katja Michael
Journal:  Molecules       Date:  2022-01-09       Impact factor: 4.927

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.